HSF Kramer Advises SEVER Life Sciences B.V. on the Sale of Nordic Group B.V.
August 12, 2026
August 12, 2026
NEW YORK, Aug. 12 -- Herbert Smith Freehills Kramer LLP, a law firm, issued the following news:
* * *
HSF Kramer advises SEVER Life Sciences B.V. on the sale of Nordic Group B.V.
Herbert Smith Freehills Kramer has advised SEVER Life Sciences B.V. on the sale of Nordic Group B.V. and its subsidiaries to the global Italian pharmaceutical company Alfasigma S.p.A. The transaction excludes Nordic Pharma Inc. in the United States, which will remain part of SEVER . . .
* * *
HSF Kramer advises SEVER Life Sciences B.V. on the sale of Nordic Group B.V.
Herbert Smith Freehills Kramer has advised SEVER Life Sciences B.V. on the sale of Nordic Group B.V. and its subsidiaries to the global Italian pharmaceutical company Alfasigma S.p.A. The transaction excludes Nordic Pharma Inc. in the United States, which will remain part of SEVER . . .